JBIO to Host June 1 Conference Call on JADE101 Phase 1 Interim Data Showing Every-12-Week Subcutaneous Dosing Potential
Jade Biosciences, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $18.59
-12% in 1h after detection
Post-detection moves
1h
-12%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS